Rep. Sensenbrenner sends second letter inquiring about U.S. government's review of controversial H5N1 studies

NewsGuard 100/100 Score

"A senior Republican in the U.S. House of Representatives is asking more questions about how the U.S. government reviewed two controversial H5N1 avian influenza studies, and how it wrote a new policy for reviewing taxpayer-funded studies that might be used for good and evil," ScienceInsider reports. Rep. Jim Sensenbrenner (R-Wisc.) "today sent a letter [.pdf] to Francis Collins, director of the National Institutes of Health (NIH), asking him to clarify how the National Science Advisory Board for Biosecurity (NSABB) reached its recent decision to recommend publication of the two studies after recommending against publication late last year," the news service writes, noting, "The letter also asks for more information on which government officials were involved" in the new policy regarding research that might be "dual use research of concern" (DURC).

"Sensenbrenner's letter appears to have been prompted, in part, by complaints about the NSABB process outlined in a letter to NIH officials written earlier this month by one member of the panel, Michael Osterholm of the University of Minnesota, Twin Cities," according to ScienceInsider. The news service notes that on March 1, Sensenbrenner wrote to White House science adviser John Holdren, "asking similar questions about how the Obama Administration has handled the H5N1 controversy," to which Holdren replied on April 9. "The letter comes as a Senate panel prepares for a hearing later this week on how the U.S. government is handling biological research that could have dual use," the news service writes (Malakoff, 4/23).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses